Healthcare -
Biotechnology - NASDAQ - US
$ 3.575
1.85 %
$ 306 M
Market Cap
-0.94
P/E
AMLX - CASH FROM OPERATIONS
Cash from Operations AMLX - Amylyx Pharmaceuticals, Inc.
11.9 M
LAST VALUE
46.95%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR